Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
about
Medication adherence and HIV symptom distress in relation to panic disorder among HIV-positive adults managing opioid dependenceDevelopment of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV.How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program.Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians.Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland.Strategies for promoting adherence to antiretroviral therapy: a review of the literaturePatient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific RegionAntiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill.Antiretroviral therapy adherence among patients living with HIV/AIDS in ThailandDelivery of HIV care during the 2007 post-election crisis in Kenya: a case study analyzing the response of the Academic Model Providing Access to Healthcare (AMPATH) programPreferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherenceBaseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs.Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited settingAn analysis of electronically monitored adherence to antiretroviral medications.A pilot feasibility and acceptability study of yoga/meditation on the quality of life and markers of stress in persons living with HIV who also use crack cocaine.Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.Stigma mediates the relationship between self-efficacy, medication adherence, and quality of life among people living with HIV/AIDS in China.Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India.Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse.Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication.Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatmentAdherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trialDevelopment and validation of an instrument to assess treatment adherence for each individual drug taken by a patientViolence, coping, and consistent medication adherence in HIV-positive couplesPlasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture.Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.Better adherence with once-daily antiretroviral regimens: a meta-analysisHow long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?Importance of dose timing to achieving undetectable viral loads.Cognitive and field testing of a new set of medication adherence self-report items for HIV care.When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!Readiness, trust, and adherence: a clinical perspective.
P2860
Q23914817-4BBFB2E1-198C-4E78-AAC6-A46683B470B5Q33477968-766DFDDF-AAE3-4C3F-8D3A-0120778AC479Q33558769-7BA05560-8289-4E21-A541-1257F3C2F462Q33572182-7AC95765-BDA5-44A6-8E2C-523B283F2F24Q33602445-AE61EE60-9CC8-4583-89C7-56ECA95F9160Q33650413-581B4308-268C-4185-9529-9E843AD0F5C9Q33764003-A1A2D839-9C99-4AA3-B5F7-9D9486D88DCCQ33873540-EEC6DBD5-7E8D-4AFA-BCC2-BA2D1D6303CCQ33917546-F1AC9A23-ADA7-47ED-B48E-FE5B7AC43B24Q33962846-547BCB21-9320-4225-8D1A-2D1F81F159EAQ34041984-D45907A4-5C96-4917-8A71-1E2A2B67C05AQ34165125-657E4D09-1156-4183-9F49-C74DFCA3547EQ34250217-A794C4EC-37A8-47F4-B83D-7820B27E9C04Q34344980-45373000-4CF5-4C00-8993-19C98ADCD04CQ34624889-3CF7B6D3-54B6-488E-8375-E11EDF6EF973Q34627306-D1EF3E19-8E8E-40AD-BFD0-5624B5330119Q34778123-B2588D27-A2D8-4811-93F5-C65FA528B74EQ35161647-821A4566-76E2-4335-B9D5-F65306AAAA74Q35193790-28A370F0-D86D-409E-A084-EE67186B5663Q35538913-AC47DD25-328A-411D-8D8A-16397CBCC2D9Q35757706-A08ACC92-76F8-4B19-A412-192310290992Q35823204-ABB6CFA9-852D-48B9-B87C-036E1ED47E86Q36039682-C4D339B4-3726-4BB1-9982-E13538F75812Q36374300-07752553-398F-4550-811A-F07ED8E4915EQ36456102-1C9E5C38-7E6A-4BC4-B345-7CFEB520E5C1Q36666541-A940387F-A561-4752-B181-FAC04CC004EEQ36784049-33BF3FEA-24CB-40D3-A5D4-D96CD3150E22Q36785804-59FF9C08-65E5-4C5E-A9DE-16CF84BA6742Q36882476-AF3C70A7-6E17-4AE8-A27F-2A4D9DC52831Q36920114-847D889F-51EB-4EF5-AE8D-ABB6D01D698FQ37072733-1580D549-5FEB-4ED2-B171-76C395EBA363Q37125639-A0AF2DAD-850A-4ABC-B464-AC2059391522Q37199040-05043C63-44FA-400A-8B1B-8511CC4B4503Q37246452-B236C1A5-DC1A-4196-8959-EF59196174B5Q37255897-679A8840-4986-4D48-802E-5FC2DF3FB768Q37341001-4602C99B-7DBF-45C3-915E-73062980A59AQ37379594-094ACDB9-AF56-4D4E-AA0E-F29BB61AFF36Q37725129-3DC92CD7-39F4-4D76-90B5-175C0D2B393FQ38021725-2263942D-E21F-4292-AFF7-F6A7460844F9Q38035824-3ACEEC06-4BDF-428E-A531-8D74EB80C12D
P2860
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Differential adherence to comb ...... gical failure with resistance.
@ast
Differential adherence to comb ...... gical failure with resistance.
@en
type
label
Differential adherence to comb ...... gical failure with resistance.
@ast
Differential adherence to comb ...... gical failure with resistance.
@en
prefLabel
Differential adherence to comb ...... gical failure with resistance.
@ast
Differential adherence to comb ...... gical failure with resistance.
@en
P2093
P2860
P1433
P1476
Differential adherence to comb ...... gical failure with resistance.
@en
P2093
Edward E Telzak
Edward M Gardner
Gerald Friedland
Grace Peng
Katherine Huppler Hullsiek
Margaret Chesney
Rodger D Macarthur
Sharon B Mannheimer
Shweta Sharma
William J Burman
P2860
P356
10.1097/QAD.0B013E3282F366FF
P407
P577
2008-01-01T00:00:00Z